ACIP issues recommendations for the prevention and control of influenza in the 1996-97 season.
D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000627:therapeutic use; D000075202:Contraindications; D006801:Humans; D017589:Immunization Programs; D007252:Influenza Vaccines; D007251:Influenza, Human / Q000188:drug therapy / Q000517:prevention & control*; D011292:Premedication; D012299:Rimantadine / Q000627:therapeutic use; D012621:Seasons; D014481:United States
D000998:Antiviral Agents; D007252:Influenza Vaccines; D012299:Rimantadine; D000547:Amantadine